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Abstract
Background: HIV-1 RT is a heterodimeric enzyme, comprising of the p66 and p51 subunits.
Earlier, we have shown that the β 7-β 8 loop of p51 is a key structural element for RT dimerization
(Pandey et al., Biochemistry 40: 9505, 2001). Deletion or alanine substitution of four amino acid
residues of this loop in the p51 subunit severely impaired DNA binding and catalytic activities of
the enzyme. To further examine the role of this loop in HIV-1 RT, we have increased its size such
that the six amino acids loop sequences are repeated in tandem and examined its impact on the
dimerization process and catalytic function of the enzyme.
Results: The polymerase and the RNase H activities of HIV-1 RT carrying insertion in the β 7-β 8
loop of both the subunits (p66INS/p51INS) were severely impaired with substantial loss of DNA
binding ability. These enzymatic activities were restored when the mutant p66INS subunit was
dimerized with the wild type p51. Glycerol gradient sedimentation analysis revealed that the
mutant p51INS subunit was unable to form stable dimer either with the wild type p66 or mutant
p66INS. Furthermore, the p66INS/p66INS mutant sedimented as a monomeric species, suggesting its
inability to form stable homodimer.
Conclusion: The data presented herein indicates that any perturbation in the β 7-β 8 loop of the
p51 subunit of HIV-1 RT affects the dimerization process resulting in substantial loss of DNA
binding ability and catalytic function of the enzyme.
Background
Human immunodeficiency virus type-1 reverse tran-
scriptase (HIV-1 RT) is a product of the gag-pol polypro-
tein precursor, which is subsequently cleaved by the pol-
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encoded protease to yield the active form of the enzyme
[1,2]. This multifunctional enzyme is responsible for cop-
ying the single stranded viral RNA genome into double
stranded proviral DNA [3,4]. HIV-1 RT is a heterodimer
consisting of a 66 and 51 kDa polypeptide chain designat-
ed as p66 and p51, respectively. The p51 subunit is gener-
ated via endoproteolytic cleavage of the p66 subunit
between Phe 440 and Tyr 441 [5,6]. The larger subunit
(p66) contains both polymerase and RNase H activities,
while the smaller subunit (p51) lacks these functions, in
context of the heterodimer [7,8]. However, both the p66
and p51 monomers are functionally inactive when disso-
ciated from each other [9]. Several years have passed since
it was first suggested that agents that could specifically dis-
rupt the dimerization of HIV-1 RT might prove a worth-
while antiretroviral strategy [10], though such agents have
yet to be developed.
Despite the fact that p51 shares an identical amino acid
sequence with the N-terminal portion of p66, the two
subunits assume different global folding patterns in the
formation of the asymmetric heterodimer [9]. Structural
determination through X-ray crystallography has revealed
that the p66 subunit of HIV-1RT has its polymerase do-
main in an "open" conformation, with its subdomains
forming a large cleft which accommodates DNA. In con-
trast, the p51 subunit assumes a compact folded confor-
mation that causes the active site residues in this subunit
to be buried and therefore, nonfunctional [11–13]. It has
been proposed that the open conformation of p66 is sup-
ported by interactions with a closed and compact p51
molecule [12,14,15]. The two subunits interact mainly via
their connection subdomains. Additional contacts, be-
tween the thumb subdomain of p51 and RNase H sub-
domain of p66 are also substantial [11,12].
Although there have been conflicting reports regarding
the DNA polymerase activity of recombinant preparations
of the p51 homodimer [16,17], it has become clear that
p51 mainly plays a supportive role in context of the p66/
p51 heterodimer. Assembly of chimeric heterodimers
formed by mixing subunits of HIV-1 RT and FIV-1 RT, has
demonstrated that the p51 subunit of HIV-1 RT helps to
preserve the functional integrity of the HIV-1 RT het-
erodimer [18]. Despite the fact that several functions have
been proposed for the p51 subunit, the mechanism
whereby p51 performs these functions has remained
largely undefined. Some of the proposed functions for
p51 include: (i) stabilizing the t-RNA primer binding for
the initiation of reverse transcription [11], (ii) enhance-
ment of strand displacement DNA synthesis [19,20], and
(iii) as a processivity factor in DNA synthesis [21].
Cys→ Ser mutation at position 280 in the p51 subunit has
been shown to alter the RNase H activity of the het-
erodimeric enzyme, indicating that this residue in the
thumb subdomain of p51 plays an important role in sup-
port of the RNase H activity of p66 [22]. The emergence of
a strain of HIV-1 resistant to the non-nucleoside RT inhib-
itor TSAO (Tertbutyldimethyl silyspiro amino oxathi-
oledioside) displaying Glu→ Lys mutation at position 138
in the p51 subunit of HIV-1 RT has also been reported
[23], thus implicating p51 to play a more direct role in
drug binding and/or the enzymatic activities of HIV-1RT.
This report was initially surprising, since Glu138 of p51
was thought to be quite distant from the purported dNTP-
binding pocket of HIV-1RT, as well as the NNRTI binding
pocket. However, in light of our recent findings implicat-
ing this loop region of p51 as a critical structural element
supporting the catalytic functions of p66, it seems feasible
that mutation at position 138 in p51 effectively altered
the binding of TSAO through its influence on the p66 cat-
alytic subunit [14].
Examination of the crystal structure of HIV-1 RT reveals
the presence of a small groove like region on the floor of
the polymerase cleft of p66 [11]. The β 7-β 8 loop of p51,
comprising of six amino acids denoted as SINNET appears
to fit into this groove-like region and likely stabilizes the
polymerase domain of p66. In an earlier communication,
we have shown that the p51 subunit of HIV-1 RT is re-
quired to load the p66 subunit on to the template primer
for DNA synthesis [14]. Our recent studies indicate that
the β 7-β 8 loop of the p51 subunit is essential for the cat-
alytic function of the p66 subunit. Deletion of this loop or
substitution of four amino acid residues with alanine
within the β 7-β 8 loop of p51 severely impaired the DNA
polymerase activity of the enzyme as a consequence of the
inability of the enzyme to form stable dimers [15]. These
findings clearly establish the absolute requirement of the
β 7-β 8 loop of p51 for RT dimerization.
Nonetheless, the question regarding the optimal size and
composition requirement of this loop for efficient dimer-
ization remains unanswered. In the present article, we
have addressed the impact of increasing the size of the β 7-
β 8 loop on the dimerization process. As a preamble to
these studies, we have increased the size of this loop by re-
peating its six amino acid sequence in tandem. The ration-
ale for duplicating the loop sequence was to increase the
size of this loop without significantly disrupting the inter-
actions seen with the wild type β 7-β 8 loop. The resulting
mutant derivatives of HIV-1 RT containing insertion of six
amino acids in the β 7-β 8 loop in either or both the subu-
nits were analyzed for their ability to form stable dimers
and other biochemical characteristics. In this article, we
present evidence that HIV-1 RT mutants, carrying inser-
tion of six amino acids in the β 7-β 8 loop specifically in
the second subunit, do not form stable dimers. This ina-
bility to dimerize substantially decreases the enzymes af-BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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finity for DNA consequently impairing its polymerase and
RNase H activities.
Results
Glycerol gradient ultra-centrifugation analysis
The ability of the HIV-1 RT mutants, carrying insertion of
six residues in the β 7-β 8 loop in either one or both the
subunits was analyzed by glycerol gradient sedimentation
analysis. Fractions of 200 µL were collected from the bot-
tom of the tube and aliquots of every third fraction were
subjected to SDS PAGE. The results shown in Figure 1A,
indicate that the sedimentation peak for the wild type
p66/p66 homodimer was between fractions 16–19 of the
gradient (Panel A), whereas the wild type p51 species sed-
imented between fractions 22–28, as a monomeric pro-
tein (Panel C). The sedimentation pattern for the p66WT/
p51INS mutant indicated two distinct peaks. While the
p66WT subunit predominantly sedimented in between
fractions 16–19, at the predicted position of the ho-
modimer, the p51INS subunit sedimented between frac-
tions 22–28, indicating a monomeric conformation
(Panel D). This sedimentation profile indicates that the
p66WT/p51INS mutant carrying the 6 amino acid insertion
in the β 7-β 8 loop of its p51 subunit is unable to form sta-
ble heterodimer. Under these conditions, the p66WT sub-
unit of the p66WT/p51INS mutant tends to homodimerize.
The mutants, p66INS/p66INS (Panel B) and p66INS/p51INS
(Panel F), exhibited a distinct sedimentation peak be-
tween fractions 22–28 of the gradient, indicating that
these enzymes are unable to form stable dimers. In con-
trast, the p66INS/p51WT mutant (Panel E), in which only
the p66 subunit carried an insertion in the β 7-β 8 loop sed-
imented between fractions 16–19 of the gradient, indicat-
ing that these two subunits can form stable heterodimers.
These analyses imply that the proper size of the β 7-β 8
loop in the second subunit of HIV-1 RT is important for
the formation of a stable dimeric enzyme.
Figure 1
(A) Sedimentation profile of the wild type and mutant HIV-1 RT. Mutant enzymes carrying 6 amino acids insertion in
the β 7-β 8 loop of either or both the subunits were applied on 10–30% linear glycerol gradient (5 mL) and centrifuged at 48,000
rpm in SW 50.1 rotor for 22 hours. Gradients were fractionated from the bottom and subjected to SDS polyacrylamide gel
electrophoresis and Coomassie Blue staining. (B) Polymerase Activity profile of the glycerol gradient fractions. Every
third fraction between 7 and 33 of the glycerol gradient (Fig. 1A) was diluted 10-fold and analyzed for its polymerase activity on
poly (rA)(dT)18 as described under Materials and Methods. The reaction products were resolved on an eight percent denatur-
ing poly-acrylamide urea gel and subjected to PhosphorImaging.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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In order to correlate the sedimentation profile of these in-
sertion mutants with their functional activity, we analyzed
the polymerase activity in the various gradient fractions.
These results are presented in Fig. 1B. The polymerase ac-
tivity profile of the gradient fractions of the wild-type p66/
p66 and the p66INS/p51WT mutant revealed major
polymerase activity peaks corresponding to fractions 16–
19 (Fig. 1B). This activity peak correlates with the protein
band intensity seen in Fig. 1A (panels A and E) and is also
in agreement with the sedimentation pattern of these two
enzymes. Interestingly, the activity profile of the p66WT/
p51INS mutant also yielded a peak corresponding to gra-
dient fractions 16–19 (Fig. 1B), thus substantiating our
contention that the p66WT subunit of the p66WT/p51INS
mutant tends to self-dimerize and form the catalytically
active p66 homodimer. The wild type p51 and the two
mutants, p66INS/p66INS and p66INS/p51INS, the sedimen-
tation profile of which indicated a monomeric conforma-
tion (Fig. 1A) were conspicuously devoid of any
polymerase activity (Fig. 1B). These results imply that the
β 7-β 8 loop of the second subunit of HIV-1 RT is critical in
forming functionally active dimeric enzyme.
DNA polymerase activities of wild type HIV-1 RT and its in-
sertion mutants
DNA polymerase activity of the wild type HIV-1 RT and its
mutant derivatives were quantitatively determined on
both heteropolymeric RNA (U5-PBS RNA) and DNA (49-
mer) templates, primed with 32P labeled 17-mer PBS
primer. As documented in Table 1, insertion of the six
amino acid segment in both the subunits (p66INS/p66INS
or p66INS/p51INS), resulted in significant loss of polymer-
ase activity corresponding to greater than 90% reduction.
Interestingly, when the p66INS mutant was dimerized
with the wild type p51 (p66INS/p51WT), the polymerase
activity was restored to wild type levels. The same result
was obtained when p66INS was dimerized with p51 hav-
ing Asp→ Ala mutation at amino acid position 186 (one
of the catalytically crucial carboxylate triad) but having an
intact β 7-β 8 loop. The rationale for using p51D186A mu-
tant was to ascertain that the wild type polymerase activity
observed with p66INS/p51WT was not due to residual
polymerase activity of p51. These results suggest that in-
sertion of six residues in the β 7-β 8 loop of p51 but not in
p66 is detrimental to the function of the heterodimeric
enzyme.
As shown in figure 2, evaluation of the polymerase activity
of the wild type HIV-1RT and its insertion mutants by
primer extension assay generally mirrored the results ob-
served in the TCA precipitation assay, summarized in Ta-
ble 1. Insertion of six amino acid residues in the β 7-β 8
loops of both the subunits (p66INS/p66INS or p66INS/
p51INS) resulted in significant impairment of polymerase
activity of the mutant enzymes. On an RNA template,
both these enzymes exhibited total lack of polymerase ac-
tivity (Fig. 2B), though the p66INS/p51INS mutant exhib-
ited residual primer extension capability on a DNA
template (Fig. 2A), while the p66INSp/66INS mutant was
inactive on this template. Consistent with the results of
the TCA precipitation assay, both the mutants, p66INS/
p51WT and p66INS/p51D186A, exhibited near wild type
(p66WT/p51WT) polymerase activity on both RNA and
DNA templates. Thus, the impairment of the polymerase
activity seen with these mutants carrying insertion in ei-
ther both the subunits or specifically in the second subu-
nit may be related to the inability of these mutants to form
stable dimers resulting in a closed polymerase cleft.
Table 1: Effect of duplication of the β 7–β 8 loop in either or both the subunits of HIV-1 RT on the polymerase activity of the enzyme
Percent of wild type polymerase Activity
Enzyme Species Poly (rA).(dT)18 U-5 PBSRNA/17-mer U-5 PBS DNA/17-mer
p66WT/p51WT 100 100 100
p66WT/p66WT 92.6 82.5 85.6
p66INS/p66INS 1.5 11 10
p66INS/p51INS 0.6 1.2 2
p66INS/p51WT 98 106 97
p66INS/p51D186A 103 116 96
p66WT/p51INS 60 57 65
The polymerase activities of the wild type HIV-1 RT and its mutant derivatives carrying insertion of 6 amino acids in the β 7-β 8 loop of either or 
both the subunits were determined with the indicated template primer at saturating dNTP concentrations. Reactions were carried out at 37°C for 
3 min and the total picomoles of nucleotide incorporated were determined. The values are expressed as a percentage of the wild type polymerase 
activity and are an average of three independent experiments.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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Effect of insertion in either or both the subunits of HIV-1 
RT on the DNA binding function of the enzyme
Earlier we have shown that substitution of four amino ac-
ids on the β 7-β 8 loop with alanine reduced the DNA
binding ability of the enzyme. Similar results were ob-
tained when four amino acids were deleted from the loop.
We therefore, concluded that the effect was exerted via
p51 since alanine substitution or deletion specifically in
the p66 subunit had no effect on DNA binding and
polymerase activity of the enzyme. We speculated that
alanine substitution or deletion in the loop of the p51
subunit may shorten the interacting sphere of the loop
which may not be able to induce opening of the polymer-
ase cleft in p66, which is essential for DNA binding. Given
the fact that shortening of this loop in p51 prevented DNA
binding, we were interested in examining the effect of six
amino acids insertion on DNA binding. Therefore, we de-
termined the equilibrium dissociation constants (Kd) of
Figure 2
Analysis of polymerase products catalyzed by insertion mutants of HIV-1 RT. Primer extension reactions catalyzed
by the wild type and mutant enzymes were on DNA (panel A) and RNA (panel B) templates, primed with 5'-32P labeled 17-mer
primer. Each set of reactions was carried out for 30 seconds (lane 1) and 60 seconds (lane 2) at 37°C and quenched by the
addition of equal volume of Sanger's gel loading dye. The reaction products were resolved on an 8% polyacrylamide-7M urea
gel and subjected to PhosphorImager analysis.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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Figure 3
DNA binding affinity of mutant HIV-1 RT carrying insertion in the β 7–β 8 loop of either or both the subunits.
The 49-mer DNA primed with 5'-32P labeled 21-mer DNA primer was incubated with varying concentrations of the individual
enzyme at 4°C for 10 min. The mixture was electrophoresed under non-denaturing conditions on a 6% (w/v) polyacrylamide
gel and analyzed on phosphorImager (Left panel). The positions of the free template primer (TP) and enzyme bound template-
primer (E-TP binary complex) are indicated for the wild type enzyme. The percent of E-TP complex formed as a function of
enzyme concentration was plotted for determining the Kd values (Right panel).BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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E-TP binary complexes for the wild type enzyme and its
mutant derivatives by gel mobility shift assay. For this pur-
pose, we used a 33-mer heteropolymeric DNA template
primed with 5' 32P-labeled 21-mer DNA. Results shown in
figure 3 and table 2 indicate a 24-fold reduction in DNA
binding affinity when both the subunits carried insertion
(p66INS/p51INS) in their β 7-β 8 loops. Similar results were
obtained with the p66INS/p66INS mutant. Interestingly,
the DNA binding affinity was restored to the wild type lev-
els, when the mutant p66 subunit was dimerized with the
wild type p51 (p66INS/p51WT). We expected that the
p66WT/p51INSmutant would also exhibit reduction in its
affinity for DNA, since insertion of six residues in the p51
subunit was speculated to be detrimental for the dimeri-
zation process. However, the DNA binding affinity of the
p66WT/p51INS mutant was similar to the wild type en-
zyme. Our glycerol gradient sedimentation analysis had
revealed that the p66WT/p51INS mutant does not form sta-
ble dimers, rather the p66WT subunit tends to self dimer-
ize. Thus, the wild type DNA binding affinity seen in case
of the p66WT/p51INS m u t an t  m ay  b e  at t r i bu t e d  t o t h e
presence of these p66WT/p66WT homodimeric species.
Based on our observations from the sedimentation analy-
sis, we propose that the loss of DNA binding function in
case of the HIV-1RT insertion mutants results from a fail-
ure to form stable dimers. The wild type p51 alone exhib-
ited very low DNA binding affinity with a Kd[DNA]1300-
fold higher than the wild type heterodimeric enzyme.
These results suggest that the optimal size of the β 7-β 8
loop in the second subunit of the HIV-1 RT dimer is cru-
cial for opening the polymerase cleft of the p66 subunit.
Ternary complex formation by the wild type and mutant 
enzymes
In the crystal structures of the ternary complex of HIV-1
RT (E-DNA-dNTP) the finger subdomain moves by 20Å
towards the palm subdomain [24]. In this finger closing
conformation, the DNA is locked in a stable ternary com-
plex poised for catalysis. An in vitro assay using dideoxy
terminated primer annealed with the template which al-
lows the next correct dNTP to bind in the ternary complex
without actual DNA synthesis has recently been reported
[25]. Using this assay system, we have evaluated the abil-
ity of the insertion mutants to form the ternary complexes
and the effect of DNA trap on such complexes. Since bind-
ing of dNTP to the enzyme is an ordered mechanism
which occurs only after DNA binding, the extent of la-
beled TP remaining bound to the enzyme in the presence
of dNTP and DNA trap represents the extent of ternary
complex formed. The E-TP binary complex was formed at
enzyme concentrations which binds 100% of the labeled
template primer. The preformed E-TP complex was then
incubated in the presence of next correct dNTP followed
by addition of 300-fold molar excess of unlabeled TP as
the DNA trap. We found that E-TP binary complex was
completely competed out by the DNA trap (data not
shown) while a significant amount of the E-TP binary
complex converted to E-TP-dNTP ternary complex was re-
sistant to competition with DNA trap (Fig. 4) suggesting
the stability of the ternary complex. Table 2 lists the appar-
ent dNTP binding affinity for the WT enzyme and its in-
sertion mutants determined from data shown in Fig. 4. It
was observed that although the DNA binding affinity was
severely affected in case of the p66INS/p51INS mutant, its
apparent dNTP binding affinity in the ternary complex
did not change with respect to the wild type enzyme.
Table 2: DNA and dNTP binding affinities of the mutant HIV-1 RT carrying insertion in the β 7–β 8 loop of either or both the subunits
Enzyme Species Kd [DNA] (nM) App. Kd [dNTP] (µM)
p66WT/p51WT 2.0 6.0
p66WT/p66WT 2.6 5.8
p66INS/p51INS 48.0 8.0
p66INS/p66INS 34.0 ND
p66INS/p51WT 4.0 9.0
p66WT/p51INS 3.0 5.0
The dissociation constant of E-TP binary complex (Kd [DNA]) and the apparent dNTP binding affinity (Kd [dNTP]) for the mutant HIV-1 RT was deter-
mined by gel mobility shift assay. For Kd [DNA] determination, 5' 32P-labeled dideoxy terminated 33/21-mer DNA template-primer was incubated 
with varying concentrations of the individual WT or mutant enzyme and resolved on a native polyacrylamide gel at 4°C. The slower migrating E-TP 
complexes were detected by phosphorImaging and quantified using ImageQuant software. For determining the apparent Kd [dNTP], the concentra-
tion of the individual enzyme used was such that retarded 100% of the labeled TP. The extent of stable E-DNA-dNTP ternary complex formed in 
the presence of varying concentrations of the next correct nucleotide (dGTP) was determined following the addition of the DNA trap. This was 
estimated by calculating the percent of the un-dissociated template primer in the ternary complex using ImageQuant software. The values shown 
are the average of two independent experiments. ND indicates that the apparent Kd [dNTP] in case of p66INS/p66INS could not be determined by 
this analysis.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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However, the p66INS/p66INS mutant was unable to form
a ternary complex. These data suggest that these two mu-
tants may have a different conformation and mode of in-
teraction in the ternary complex. It is apparent that the
p66INS/p66INS binds to TP in a nonproductive manner
which may have a direct impact on dNTP binding in the
ternary complex.
Steady state kinetic analysis of HIV-1 RT and its insertion 
mutants
In order to determine whether alteration in DNA binding
without any change in the apparent dNTP binding affinity
of the insertion mutants is consistent with their kinetic pa-
rameters, we analyzed the steady-state kinetic parameters
of these mutants. The results of this investigation are sum-
marized in Table 3. On poly (rA).(dT)18, only the p66INS/
p66INS mutant showed a significant increase in Km [dNTP].
Figure 4
Apparent dNTP binding affinity of mutant HIV-1 RT carrying insertion in the β 7–β 8 loop of either or both the
subunits. The 33-mer DNA primed with 5'-32P labeled dideoxy (ddC) terminated 21-mer DNA primer was incubated with
the individual enzyme at 4°C for 10 min. The binding affinity [Kd (dNTP)] of the wild type enzyme and its mutant derivatives in
the ternary complex was determined by incubating the preformed E-TP binary complex of the individual enzyme species at dif-
ferent concentrations (0.26–800 µM) of the next correct dNTP (dGTP). Following incubation with dGTP, 300 fold molar
excess of the unlabeled TP was used as trap to remove the readily dissociable binary complexes from the ternary complex
population. The extent of stable ternary complexes formed were resolved on 6% native polyacrylamide gel and analyzed by
phosphorImaging. The [Kd [dNTP]], in the ternary complex for each enzyme was determined by quantifying the E-TP-dNTP ter-
nary complexes as a function of increasing concentrations of dGTP and fitting the data to the equation for single-site ligand
binding using Sigma-Plot. Lanes 1–6 represent the ternary complex formed in the presence of dGTP at 0.2, 1.28, 6.4, 32, 160
and 800 µM, concentrations.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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This observation is in agreement with the apparent dNTP
binding affinity data in the ternary complex, where
p66INS/p66INS mutant was found to be defective in form-
ing a productive ternary complex. This observation is also
consistent with our suggestion that p66INS/p66INS binds
nonproductively to TP that may influence the formation
of ternary complexes. Interestingly, the p66INS/
p51INSmutant carrying insertion in both the subunits did
not display the same reduction in dTTP binding affinity.
However, the p66INS/p66INS and p66INS/p51INS mutants
displayed nearly 6,000-fold and 400-fold reduction in cat-
alytic efficiency (kcat/Km) compared to their wild type
counterparts, respectively, on this template primer. A 10-
fold reduction in catalytic efficiency in case of the p66INS/
p51WT was noted only on poly (rA). (dT)18 and may be
template-primer specific. None of the enzymes displayed
a significant reduction in Km [dNTP] when the heteropoly-
meric DNA\DNA template primer was used, although the
p66INS/p66INS and p66INS/p51INS mutants exhibited
drastic reduction in catalytic efficiency. The p66WT/
p51INSdisplayed no change in either dNTP binding or cat-
alytic efficiency. These results are in keeping with our
analysis of the polymerase and DNA binding assay for this
mutant. Once again, we believe that the wild type p66
subunit in this enzyme preparation tends to homodimer-
ize since the p51INS fails to participate in stable dimer for-
mation. This phenomenon masks the deleterious effect of
the insertion mutation.
RNase H activity of the insertion mutants
Since the polymerase activity of the homo- and hetero-
dimeric enzymes carrying insertion in the β 7-β 8 loop in
both the subunits (p66INS/p66INS and p66INS/p51INS)
was drastically impaired, it was of interest to examine how
this insertion affects their RNase H activity. To evaluate
this, we employed a 30-mer RNA-DNA hybrid, and exam-
ined the cleavage of the 5'-32P-RNA strand of the duplex
by the wild type enzyme and its mutant derivatives. The
result of this analysis is presented in Fig. 5. Similar to their
Table 3: Steady-State kinetic parameters of mutant HIV-1 RT carrying insertion in the β 7–β 8 loop of either or both the subunits
Poly (rA).(dT)18 U-5 PBS 49-mer DNA/17 mer
Enzyme Km (dTTP) 
(µM)
kcat (S-1)102 kcat/Km (S-1M-1) 
×  104
Km (dNTP) 
(µM)
kcat (S-1)103 kcat/Km (S-1M-1) 
×  104
p66WT/p66WT 5.01 135.7 27.08 2.10 15.8 0.754
p66WT/p51WT 5.48 103.7 18.93 3.91 25.0 0.641
p66INS/p66INS 46.39 0.198 0.0043 6.05 0.400 0.0063
p66INS/p51WT 2.57 43.7 1.702 5.47 15.00 0.270
p66WT/p51INS 4.86 89.8 18.490 2.35 15.40 0.655
p66INS/p51INS 3.35 0.15 0.0448 5.71 0.300 0.0046
Kinetic parameters of the wild type HIV-1RT and its mutant derivatives were determined on homopolymeric RNA (poly rA) and heteropolymeric 
DNA (U5-PBS 49-mer) templates with (dT)18 and 17 mer DNA as primers, respectively. The values obtained are the average of three independent 
experiments.
Figure 5
RNase H activity of the wild-type HIV-1 RT and its
mutant derivatives. The individual enzymes were incu-
bated with 5'-32P-labeled 30-mer RNA annealed with 30-mer
complementary DNA strand, at 37° for 30 sec and 1 min as
described in Materials and Methods. The cleavage products
were resolved on an 8% denaturing polyacrylamide-urea gel
and analyzed on a phosphorImager. Lanes 1 and 2 represent
reactions carried out for 30 sec and 1 min, respectively.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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polymerase activities, the RNase H activities of the
p66INS/p66INS and p66INS/p51INS mutants were severely
impaired. This is not surprising, since our analysis of the
DNA binding function of these two mutants had indicat-
ed a substantial loss of DNA binding affinity, which in
turn is expected to affect both the polymerase and RNase
H functions. Dimerization of the p66INS subunit with the
wild type p51 (p66INS/p51WT) carrying an intact β 7-β 8
loop resulted in substantial recovery of the RNase H activ-
ity. The RNase H activity seen in case of the p66WT/p51INS
mutant was not surprising since the p66WT subunit of the
p66WT/p51INSmutant tends to self-dimerize and form the
catalytically active p66 homodimer.
Discussion
In an earlier investigation on the role of the p51 subunit
of HIV-1 RT, we demonstrated that decrease in size of its
β 7-β 8 loop impairs the catalytic function of the het-
erodimer [15]. In the present studies, we demonstrate that
maintaining the wild type size of this loop in the p51 sub-
unit is critical for dimerization of the enzyme and its cat-
alytic activity. Duplication of the β 7-β 8 loop sequence
selectively in the p66 subunit did not affect the dimer for-
mation, DNA binding or polymerase activity of the
p66INS/p51WT mutant. However, insertion of the same
amino acid residues in the β 7-β 8 loop of p51 prevented
stable dimerization of the p51INS subunit with either
p66INS or p66WT and adversely impacted the DNA bind-
ing, polymerase and RNase H activities. Earlier, we have
shown that p51 facilitates the loading of the p66 subunit
on to the template primer [14]. Therefore, the impaired
polymerase activity and template-primer binding affinity
of HIV-1 RT mutants carrying insertion in p51 may be due
to their inability to load the catalytic p66 (p66INS) on the
template primer. These altered biophysical/enzymatic
properties of these insertion mutants may be attributed to
the reduced dimer stability.
Crystal structures of HIV-1 RT show that p66 and p51 as-
sume different folding patterns and tertiary structures
[11,12]. It has been proposed that p66 in a monomeric
form exists in a closed conformation similar to p51 [26].
Following dimerization with another molecule of p51 (or
p66), it assumes an open conformation [11,14,15]. The
polymerase domain of p51 is buried within its core. This
difference in tertiary structures between the two subunits
makes the dimer asymmetric. The amino acid residues at
the contact interface differ with respect to their position
and location in the 3-D structure. The counterpart of ami-
no acid residues of p66 located at the contact interface are
buried in the p51 folded conformation, whereas those of
p51 are scattered in the p66 'open' conformation (Fig. 6).
Of the several domain interactions between p66 and p51,
the β 7-β 8 loop of p51 is strategically positioned to inter-
act with the residues on the floor of the palm subdomain
of p66. It has been suggested that the stability of the dimer
is related to the buried surface area between the two sub-
units [11,12]. In the nevirapine-bound HIV-1 RT crystal
structure, the total contact surface area between the subu-
nits is approximately ~4600 Å2. The two major contact re-
gions between the subunits which provide it stability are
their connection subdomains and the thumb of p51 and
RNase H domain of p66. These contacts account for ap-
proximately two third of the total buried surface area. In-
terestingly, the marginal decrease in the total surface area
due to deletion of four residues in the β 7-β 8 loop does not
account for the dimer instability, thus suggesting that po-
Figure 6
Amino acid residues in the p51 subunit in contact
with the p66 subunit. The Cα  backbone of p51 and p66 is
shown in orange and green, respectively. Amino acids resi-
dues of p51 making contact with the p66 subunit are repre-
sented as 'sticks' and are shown encircled. The location of
analogous residues in p66 are also encircled. It may be noted
that these residues in p66 are scattered. The residues circled
within 'blue' are from fingers; those in light blue' are from
'connection' and those in pink are from 'thumb' subdomains.
The template (blue) and primer (gray) are also displayed in
this figure. The residues in blue circle are V21, K22, P25, P52,
E53, N57, T131, N136, N137, E138, T139, in light blue circle
are P392, I393, Q394, E396, T397, T400, W401, N418, P420,
L422, and those in pink circle are N255, Q258, V261, N265,
V276, L283, T286, L289.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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lar interactions of residues in the β 7-β 8 loop of p51 with
the palm subdomain of p66 may play a role in conferring
stability to the heterodimer. The observation that a single
point mutation at L289 of p66, a residue not in direct con-
tact with p51, also destabilizes the dimer [27,28] indicates
that other factors may also contribute towards dimer sta-
bility.
In order to analyze the impact of inserting the six amino
acid peptide in the β 7-β 8 loop of p51, we used the molec-
ular modeling approach. A search in the database of
known protein structures employing the 'loop-search' al-
gorithm of SYBYL yielded 100 loops, of which only five
were sterically permissible. The loop exhibiting the best
homology was incorporated in the modeled structure
(Fig. 7). This loop of 9 amino acids (RFNAHGDVN) from
the protein S. lectin formed a short anti-parallel two
strand β -sheet. This inserted loop lies in the vicinity of the
palm subdomain of p66 and exhibits additional hydro-
phobic and polar interactions with residues in the palm
subdomain of p66, not seen in the wild type structure.
These additional interactions are expected to enhance the
stability of the dimer. However, sedimentation analysis
indicates that the insertion mutants form unstable dimer.
This implies that the insertion may have altered the rela-
tive position of the subdomains in the two subunits there-
by perturbing the dimer stability. In summary, the β 7-β 8
loop of p51 is an important structural element involved in
imparting stability to the heterodimer and in opening the
polymerase cleft of p66 for catalysis.
Materials and methods
PfuTurbo DNA polymerase and PCR reagents were ob-
tained from Stratagene, Inc. Restriction endonucleases,
DNA modifying enzymes and HPLC-purified dNTPs were
purchased from Roche Molecular Biochemicals. Fast flow
chelating sepharose (iminodiacetic-Sepharose) for immo-
bilized metal affinity chromatography (IMAC), Phos-
phocellulose and Q-sepharose was purchased from
Amersham Pharmacia Biotech. The α -32P-dNTPs and γ -
32P-ATP were purchased from Perkin Elmer life sciences.
The DNA oligomers were synthesized at the Molecular Re-
source Facility at UMDNJ. All other reagents and chemi-
cals were of the highest available purity grade and
purchased from Fisher, Millipore Corp., Roche Molecular
and Bio-Rad.
Plasmid and clones
The expression vector pET-28a and E. coli expression strain
BL21 (DE3) were obtained from Novagen. The HIV-1RT
expression clones (pKK223-3 RT66 and pET-28a-RT51)
constructed in this laboratory [29–31] were used for PCR
amplification and construction of the insertion mutants
in the p66 and p51 subunits of HIV-1 RT. An HIV-RNA ex-
pression clone pHIV-PBS was a generous gift from Dr. M.
A. Wainberg [32].
Insertion of 6 amino acid residues in the β 7–β 8 loop
The pKK-RT66 clone containing two unique restriction
sites, Hpa1 and Stu1, at codons 136 and 140 in the RT cod-
ing region [15] was used for insertion of 6 amino-acid res-
idues in the β 7-β 8 loop of the p66 and p51 subunit. The
pKK-RT66 clone was digested with HpaI restriction en-
zyme to generate a blunt end at codon 136. For insertion,
two complementary pre-kinased 18-mer synthetic DNA
oligos having the following sequences: 5'-ATA AAC AAT
GAG ACA ATA-3 (sense strand) and 3'-TAT TTG TTA CTC
TGT TAT-5' (antisense strand) were hybridized. The 18-
mer duplex DNA encoding the insertion peptide (Ile-Asn-
Asn-Glu-Thr-Ile) was ligated with Hpa1 digested pKK-
RT66 in between codon 135 and 136. The positive clones
were screened in E. coli HB101 by the absence of an Hpa1
site and the correct orientation of the insertion was con-
Figure 7
Molecular model of the inserted peptide in the β 7–β 8
loop of the p51 subunit. Molecular modeling of the
extended loop was performed by the 'Loop Search' option of
SYBYL version 6.5 (Tripos Associates, St. Louis, MO). A total
of 100 loops, matching the Cα  distances constrain between
the end points of the loop residues, were obtained. The
loops were examined for 'bumps' with the neighboring pro-
tein structure. Selection of the appropriate loop was based
on the least root mean square deviation and maximum
homology with the inserted loop sequence. A loop satisfying
these criteria containing two small anti-parallel β -strands is
shown in cyan. The side chains of amino acid residues of p66
are shown in green and those of p51 (wild type) are shown in
orange. The side chains of interacting residues in the inserted
peptide are colored violet and are indicated by their position
number in parentheses. Interactions seen in the wild type
loop are shown in blue dotted line while additional interac-
tions are shown in black dotted lines.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
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firmed by DNA sequencing. This construct expresses the
p66+6aa subunit without His tag sequences. A His-tag at
the N-terminal of the p66+6aa subunit was introduced by
sub cloning the Bal-I and Hind III fragment of
pKKRT66+6aa into pET-28a-RT66 expression cassette. A
unique Sac I site was also introduced in pKK-RT66 tem-
plate at codon 440. The construction of P51+6aa was car-
ried out by removal of the 360 bp fragment from pKK-
RT66+6aa by restriction digestion with SacI followed by
re-ligation of the vector ends. The insertion mutant in
pET28a and pKK223-3 vectors were introduced into E. coli
BL-21 (DE3) pLys S and E. coli JM109, respectively, for ex-
pression. Induction of the enzyme protein was carried out
as described before for the wild type HIV-1RT [29]. The
enzyme with the hexahistidine-tag was purified from bac-
terial lysates by immobilized metal affinity chromatogra-
phy [33], while non-hexahistidine-tagged enzyme was
purified using the phosphocellulose and Q-Sepharose col-
umns as described previously [24].
Preparation of the heterodimeric enzyme with subunit spe-
cific insertion
The p51 subunit with a hexahistidine-tag and a non-
tagged p66 were used to generate the heterodimers con-
taining insertion in either or both of the subunits. For
each set of heterodimers, 260 µg of p51 was mixed with
660 µg of p66 in the buffer containing 50 mM Tris HCl,
pH 7.8, 60 mM KCl and 5 mM MgCl2. The rationale for
using a 1:3 ratio of p51 to p66 was to saturate the His-
tagged p51 with the non-tagged p66, ensuring heterodim-
er formation and eliminating excess p66 during IMAC pu-
rification. The mixture was incubated for 16 hours at 4°C
and applied to (0.5 mL) Ni2+ iminodiacetic-Sepharose
(IDA-Sepharose) column, which was pre-equilibrated
with the binding buffer (20 mM Tris HCl pH 7.8, 500 mM
NaCl and 5 mM Imidazole). The column was washed with
15 mL of the same buffer to remove the excess of p66 that
was not dimerized with p51 bound to the IDA-sepharose
column. The heterodimeric RT was then eluted from the
column with elution buffer (20 mM Tris HCl pH 7.8, 500
mM NaCl and 250 mM imidazole). Fractions of 0.5 mL
were collected and an aliquot of each fraction was ana-
lyzed by SDS-PAGE using Coomassie Blue stain. The frac-
tions containing approximately equal band intensity of
p66 and p51 were dialyzed against a storage buffer (50
mM Tris HCl pH 7.0, 200 mM NaCl and 50% Glycerol)
and this enzyme preparation was used in all experiments.
Glycerol gradient ultra centrifugation
Fifty micrograms of the enzyme protein in 100 µL of buff-
er (50 mM Tris HCl, pH 7.8, 1 mM DTT and 400 mM Na-
Cl) was carefully loaded onto 5 mL of 10–30% glycerol
gradients prepared in the same buffer. The gradients were
centrifuged at 48,000 rpm in an SW48 rotor for 22 h at
4°C. Fractions (200 µL) were collected from the bottom of
the tube and aliquots of these fractions were electro-
phoresed using SDS PAGE and Coomassie Blue stain to
identify the protein peak.
The polymerase activity in the gradient fractions were an-
alyzed by extension of the labeled (dT)18 annealed to poly
(rA) template. Every third fraction between 7 and 33 of
the glycerol gradient was diluted 10-fold and analyzed for
its polymerase activity. Reactions were carried out at 37°C
for 2 min at 20 µM dTTP concentration and quenched
with Sanger's gel loading dye [35]. The reaction products
were resolved by denaturing polyacrylamide-urea gel elec-
trophoresis and analyzed on a PhosphorImager (Molecu-
lar Dynamics, Inc.).
DNA polymerase assay
Polymerase activity of the HIV-1RT WT and insertion mu-
tant enzymes was determined using two different tem-
plate-primers: U-5PBS HIV-1 RNA and synthetic 49-mer
U5-PBS DNA templates primed with the 17-mer PBS
primer [36]. Assays were carried out in a 50 µL volume
containing 50 mM Tris HCl, pH 7.8, 100 µg/mL bovine se-
rum albumin, 5 mM MgCl2, 1 mM dithiothreitol, 60 mM
KCl, 100 nM template-primer, 50 µM of each of the four
dNTPs with one of them being 32P-labeled (0.1 µCi/nmol
dNTP) and 21 nM enzyme. Reactions were incubated at
37°C for 3 min and terminated by the addition of ice-cold
5% trichloroacetic acid containing 5 mM inorganic pyro-
phosphate. Following termination, the reaction mixtures
were filtered on Whatman GF/B filters. The filters were
then dried, immersed in scintillation fluid and counted in
a liquid scintillation counter.
Gel analysis of RNA and DNA dependent polymerase ac-
tivities
The U5-PBS HIV-1 RNA and heteropolymeric synthetic
U5-PBS HIV-1 DNA templates primed with the 17-mer
PBS DNA primer were used to assess the polymerase activ-
ities of the wild type and mutant heterodimeric enzymes.
The primers were 5'-labeled using γ -32P-ATP and T4 poly-
nucleotide kinase according to the standard protocol [37].
Polymerase reactions were carried out by incubating 2.5
nM template primer with 50 nM of the wild type HIV-1RT
or its mutant derivative in a total reaction volume of 6 µL
containing 25 mM Tris-HCl, pH 7.5, 10 mM dithiothrei-
tol, 100 µg/mL bovine serum albumin, 5 mM MgCl2 and
50 µM of each dNTP. Reactions were initiated by the ad-
dition of enzyme and terminated by the addition of an
equal volume (6 µL) of Sanger's gel loading dye [35]. The
reaction products were resolved by denaturing poly acry-
lamide-urea gel electrophoresis and analyzed on a Phos-
phorImager (Molecular Dynamics, Inc.).BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/18
Page 13 of 14
(page number not for citation purposes)
Template-Primer (TP) binding affinity of the wild type en-
zyme and its mutant derivatives
The dissociation constants (Kd) of the E-TP binary com-
plexes of the wild type HIV-1 RT and its mutant deriva-
tives were determined as described by Tong et al. [25]. The
heteropolymeric 33-mer DNA (0.4 nM) annealed to 5'-
32P-labeled 21-mer primer (0.3 nM) was incubated with
varying concentrations of the wild type enzyme and its
mutant derivatives in a total volume of 10 µL containing
50 mM Tris-HCl, pH 7.8, 5 mM MgCl2 and 0.01 % BSA.
Following incubation of the mixture for 10 min at 4°C,
equal volume of 2×  gel-loading dye containing 0.25%
bromophenol blue and 20% glycerol was added. The E-TP
binary complexes formed were resolved at 4°C on 6% na-
tive polyacrylamide gel using Tris-Borate buffer (85 mM
Tris, 85 mM Boric acid, pH 8.0). The amounts of the TP in
the binary complex (E-TP) and in free form with respect to
the varying concentrations of the enzyme protein were de-
termined by PhosphorImager (Molecular Dynamics,
Pharmacia) analysis of the gel. The fraction of the bound
DNA was plotted against enzyme concentration and the
Kd [DNA] value was determined as the RT concentration at
which 50% of DNA is bound.
Ternary complex formation assay
The ternary complex (E-DNA-dNTP) formation was as-
sessed by incubating the binary complexes of enzyme and
dideoxy terminated template primer in the presence of
next correct dNTP [25]. The binary complexes were
formed by incubating 10–50 nM of the wild type enzyme
or its mutant derivatives with 0.3 nM of 5'-32P-labeled
dideoxy terminated 33-mer/21-mer template-primer as
described above. The chosen concentration of enzyme
was such that resulted in almost complete shift during E-
TP complex formation. The E-TP-dNTP ternary complex
formation was assessed by the addition of dNTP comple-
mentary to the next template base (in this case dGTP, 200
µM). Following incubation with dNTP at 4°C for 10 min,
300 fold molar excess of a DNA trap was added to the in-
cubation mixture to assess the stability of the binary and
ternary complexes formed by the enzyme. The complexes
were resolved on a 6% native polyacrylamide followed by
phosphorImaging. The extent of E-TP-dNTP ternary com-
plexes formed was quantified using ImageQuant software.
RNase H activity assay
We used a 5'-32P labeled 30-mer synthetic U5-PBS RNA
template annealed with a complementary 30-mer DNA to
determine the RNase H activity of the enzymes [31]. The
reaction mixture contained labeled RNA-DNA hybrid (10
K Cerenkov cpm), 50 mM Tris-HCl pH 8.0, 60 mM KCl,
10 mM dithiothreitol, 0.1 mg/ml bovine serum albumin,
5 mM MgCl2, and 20 ng of enzyme in a final volume of 5
µl. Reactions were carried out at 37°C for 30 sec and 1 min
and terminated by the addition of equal volume of
Sanger's gel loading dye [35]. The cleavage products were
analyzed on an 8% denaturing polyacrylamide-urea gel
and scanned on a phosphorImager (Molecular Dynamics
Inc.).
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